Anindita Das

Dr. Anindita Das

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2007 in Indian Journal of Medical Microbiology
Verified
Journal Article
Open access
PRP Ray
P Ray
ADAnindita Das
Anindita Das
VGVikas Gautam
Vikas Gautam
NJN Jain
N Jain
ANA Narang
A Narang
MARYADA SHARMAMARYADA SHARMA
MARYADA SHARMA

19 September 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
ACAnthea Cheng
Anthea Cheng
ADAnindita Das
Anindita Das
KCKhin Chaw
Khin Chaw
PDPeta M. Dennington
Peta M. Dennington
CSClaire Styles
Claire Styles
IGIain B. Gosbell
Iain B. Gosbell
Transfusion-transmitted bacterial infection (TTBI) is the leading cause of transfusion-transmitted infections. Platelet components are more likely to be associated with bacterial contamination due to their storage requirements. Australian Red Cross Lifeblood introduced the bacterial contamination screening (BCS) of all platelet components in 2008. The process was recently updated with the use of BACT/ALERT® VIRTUO®, a large-volume delayed sampling (LVDS) protocol and extending platelet shelf-life to seven days. This article describes the results from the routine BCS of platelet components in Australia. Use of VIRTUO has resulted in lower false-positive rates, reducing wastage and improving platelet inventory. Our findings show that the combination of LVDS and VIRTUO improves the safety of platelet transfusions through earlier time to detection, especially for pathogenic bacterial species. Pathogenic bacteria grew within 24 h of incubation with a clear delineation between pathogenic and non-pathogenic species. The data show this protocol is very safe, with no TTBI cases during this time. There were no TTBI reports in recipients of platelet components that subsequently had a positive culture with Cutibacterium species, probably due to the low pathogenic potential of these organisms and slow replication in aerobic platelet bags. We conclude there is no advantage in incubating culture bottles beyond five days.

14 August 2024 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
ACAnthea Cheng
Anthea Cheng
ADAnindita Das
Anindita Das
CSClaire Styles
Claire Styles
ZNZin Naing
Zin Naing
WRWiliam Rawlinson
Wiliam Rawlinson
IGIain B. Gosbell
Iain B. Gosbell
Using sequential immunoassays for the screening of blood donors is well described for viral serology testing but not for the screening of syphilis. In this study, we report the evaluation results and 2-year sequential testing data using two highly sensitive automated serology assays, the Alinity s Syphilis chemiluminescent immunoassay for screening, with all repeatedly reactive samples then tested on the Elecsys Syphilis electrochemiluminescence immunoassay. We screened 1,767,782 blood donor samples between 7 July 2021 and 6 July 2023 and found the Alinity false-positive rate to be low at 0.08% (1,456/1,767,782). The common false-positive rate between the two assays was also low (3.83%, 58/1,514). Concordantly reactive samples were further tested using a Treponema pallidum particle agglutination test, a rapid plasma reagin test, and a fluorescent treponemal antibody absorption test. There were 262/1,376 concordantly reactive Alinity and Elecsys blood donor samples with reactivity on one or more of the confirmatory tests. A total of 26/1,376 donors had a current syphilis infection, 152/1,376 reported a past history of syphilis and had been treated, and 84/1,376 did not report a past history of syphilis. We suggest that future studies could explore the use of sequential immunoassays to aid in the serodiagnosis for syphilis. IMPORTANCE: The serodiagnosis for syphilis usually follows two methodologies—a “traditional” algorithm using a non-treponemal test followed by confirmation using a treponemal test, or a “reverse” algorithm using a treponemal test followed by a non-treponemal test. There are limited reports in the literature of using a modified reverse algorithm (treponemal test followed by a second treponemal test), and to the best of knowledge, there are currently no published articles using two highly sensitive automated immunoassays to aid the serodiagnosis of syphilis. In addition, the Treponema pallidum particle agglutination (TPPA) assay is commonly used as a confirmatory test for the diagnosis of syphilis. With the withdrawal of the TPPA assay from Australia and presumably from the global market also, alternative testing algorithms are now required. This study provides proof of concept for using sequential immunoassays in the diagnosis of syphilis.


14 April 2022 in Endoscopy
Verified
Journal Article
Closed access
JSJayanta Samanta
Jayanta Samanta
RCRadhika Chavan
Radhika Chavan
PGParakriti Gupta
Parakriti Gupta
LCL. Chalamarla
L. Chalamarla
JDJahnvi Dhar
Jahnvi Dhar
DRD.N. Reddy
D.N. Reddy
Aims Liver biopsy can be performed by the traditional percutaneous radiology guided route (PC-LB) or under endoscopic ultrasound guidance (EUS-LB) and limited data exist on the comparison between the two and hence this study was planned. Methods This is a parallel-group, single-blinded, randomized controlled trial conducted at two tertiary care centers in India from July 2020-August 2021. Consecutive patients requiring liver biopsy were randomized into either the EUS-LB or the PC-LB arm. Aggregate specimen length, longest specimen length, number of complete portal tracts (CPTs), and diagnostic adequacy were assessed. Post-procedure pain was measured using the visual analog scale (VAS) at 1, 4, and 24 hrs post-procedure. Results A total of 48 patients (30 males; 62.5% with a mean age of 37.25±12.7 years) were randomized into EUS-LB (n=24) and PC-LB (n=24). EUS-LB yielded significantly greater aggregate specimen length (33.5 vs 15.0 mm; p<0.0001) and a higher number of CPTs (17.5 vs. 7.5; p<0.001). The longest length of the specimen was noted in PC-LB arm (10.5 vs. 8.0;p=0.04). Diagnostic adequacy was similar between the two arms. The most common post-procedure side effect was pain. Pain was noted in higher proportion in PC-LB arm (87.5% vs. 16.7%; p<0.001) and had higher analgesic requirement (41.7% vs 4.2%;p=0.004). VAS score was significantly higher in the PC-LB at all the measured time points of 1, 4, and 24 hrs (p<0.001). Conclusions EUS-LB showed significantly better aggregate specimen length and more CPTs compared to PC-LB. Post-procedure pain in the first 24 hrs was significantly greater in the PC-LB arm.(Trial No:CTRI/2020/09/027989) Publication Date: 14 April 2022 (online) © 2022. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany